Last 12 months
Inside the activity.
9 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 5 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2023 Filed Jun 17, 2023 00:13 UTC |
Bonnefoy LucPresident,Surgical
|
GrantCommon Shares, No Par Value | 5,361 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-015847 · doc4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,729 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which is scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| May 04, 2023 Filed May 5, 2023 16:19 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 12,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014685 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,900 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 04, 2023 Filed May 5, 2023 21:34 UTC |
Bailey A Robert DEVP & Chief Legal Officer
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 429,184 | $0.00 Strike: $17.50 | $0.00 |
DisclosureSEC source: 0001127602-23-014768 · form4.xml · derivative · entry 1 Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 429,184 Underlying: Common Shares, No Par Value · 429,184 shares Expires 2033-05-04 F1 · derivative.exercise_date: Reflects an award of stock options to purchase common shares granted to the reporting person under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan on May 4, 2023. Each stock option reflects the right to purchase one common share, subject to the terms of the Plan and the applicable award agreement. The stock options are scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject generally to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:33 UTC |
VON ESCHENBACH ANDREW C.Director
|
GrantCommon Shares, No Par Value | 12,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014715 · form4.xml · nonDerivative · entry 1 VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,357 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:32 UTC |
Ross Thomas W. Sr.Director
|
GrantCommon Shares, No Par Value | 12,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014713 · form4.xml · nonDerivative · entry 1 Ross Thomas W. Sr. · CIK 0001669396 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,357 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:31 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 12,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014709 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,136 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:29 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 12,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014705 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,613 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:27 UTC |
KAVANAGH SARAH BDirector
|
GrantCommon Shares, No Par Value | 12,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014702 · form4.xml · nonDerivative · entry 1 KAVANAGH SARAH B · CIK 0001681171 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,665 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:24 UTC |
ICAHN BRETTDirector
|
GrantCommon Shares, No Par Value | 12,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014696 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,113 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:20 UTC |
Hu GaoxiangDirector
|
GrantCommon Shares, No Par Value | 12,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014688 · form4.xml · nonDerivative · entry 1 Hu Gaoxiang · CIK 0001839091 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,113 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:17 UTC |
Bernier Nathalie D.Director
|
GrantCommon Shares, No Par Value | 12,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014684 · form4.xml · nonDerivative · entry 1 Bernier Nathalie D. · CIK 0001903043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,445 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:22 UTC |
Stewart Andrew J.See remarks
|
GrantCommon Shares, No Par Value | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-013582 · form4.xml · nonDerivative · entry 1 Stewart Andrew J. · CIK 0001974516 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,150 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:20 UTC |
Bailey A Robert DEVP & Chief Legal Officer
|
GrantCommon Shares, No Par Value | 120,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-013581 · form4.xml · nonDerivative · entry 1 Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,500 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 20:51 UTC |
ROBERTSON RUSSEL CDirector
|
Tax withholdingCommon Shares, No Par Value | 6,692 | $17.12 | $114,567.04 |
DisclosureSEC source: 0001127602-23-013574 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,279 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 20:50 UTC |
Bernier Nathalie D.Director
|
Tax withholdingCommon Shares, No Par Value | 227 | $17.12 | $3,886.24 |
DisclosureSEC source: 0001127602-23-013572 · form4.xml · nonDerivative · entry 1 Bernier Nathalie D. · CIK 0001903043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,588 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 20:48 UTC |
KAVANAGH SARAH BDirector
|
Tax withholdingCommon Shares, No Par Value | 6,692 | $17.12 | $114,567.04 |
DisclosureSEC source: 0001127602-23-013570 · form4.xml · nonDerivative · entry 1 KAVANAGH SARAH B · CIK 0001681171 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,808 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 16:16 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 1,543 | $17.41 | $26,863.63 |
DisclosureSEC source: 0001127602-23-012184 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,043 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:26 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 1,471 | $17.41 | $25,610.11 |
DisclosureSEC source: 0001127602-23-012218 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,971 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:22 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,256 | $17.41 | $21,866.96 |
DisclosureSEC source: 0001127602-23-012204 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,756 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:12 UTC |
Bernier Nathalie D.Director
|
GrantCommon Shares, No Par Value | 1,435 | $17.41 | $24,983.35 |
DisclosureSEC source: 0001127602-23-012173 · form4.xml · nonDerivative · entry 1 Bernier Nathalie D. · CIK 0001903043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,815 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:01 UTC |
Hashad YehiaEVP, R&D and CMO
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 56,715 | $0.00 Strike: $17.96 | $0.00 |
DisclosureSEC source: 0001127602-23-008781 · form4.xml · derivative · entry 2 Hashad Yehia · CIK 0001877701 · EVP, R&D and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,715 Underlying: Common Shares, No Par Value · 56,715 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase Common Shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:01 UTC |
Hashad YehiaEVP, R&D and CMO
|
GrantCommon Shares, No Par Value | 17,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008781 · form4.xml · nonDerivative · entry 1 Hashad Yehia · CIK 0001877701 · EVP, R&D and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,437 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:04 UTC |
Munsch FrederickSVP, Controller and CAO
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 24,103 | $0.00 Strike: $17.96 | $0.00 |
DisclosureSEC source: 0001127602-23-008787 · form4.xml · derivative · entry 2 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,103 Underlying: Common Shares, No Par Value · 24,103 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase Common Shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:04 UTC |
Munsch FrederickSVP, Controller and CAO
|
GrantCommon Shares, No Par Value | 7,529 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008787 · form4.xml · nonDerivative · entry 1 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,251 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:59 UTC |
Gordon Joseph FPlease see remarks
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 68,058 | $0.00 Strike: $17.96 | $0.00 |
DisclosureSEC source: 0001127602-23-008778 · form4.xml · derivative · entry 2 Gordon Joseph F · CIK 0001749876 · Please see remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,058 Underlying: Common Shares, No Par Value · 68,058 shares Expires not disclosed F2 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F3 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:59 UTC |
Gordon Joseph FPlease see remarks
|
GrantCommon Shares, No Par Value | 21,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008778 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Please see remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,702 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:55 UTC |
ACKERMANN CHRISTINAPlease see remarks
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 90,744 | $17.96 Strike: $17.96 | $1,629,762.24 |
DisclosureSEC source: 0001127602-23-008771 · form4.xml · derivative · entry 2 ACKERMANN CHRISTINA · CIK 0001681871 · Please see remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,744 Underlying: Common Shares, No Par Value · 90,744 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase Common Shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:55 UTC |
ACKERMANN CHRISTINAPlease see remarks
|
GrantCommon Shares, No Par Value | 28,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008771 · form4.xml · nonDerivative · entry 1 ACKERMANN CHRISTINA · CIK 0001681871 · Please see remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,677 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:56 UTC |
Eldessouky SamChief Financial Officer
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 136,116 | $0.00 Strike: $17.96 | $0.00 |
DisclosureSEC source: 0001127602-23-008774 · form4.xml · derivative · entry 2 Eldessouky Sam · CIK 0001558676 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,116 Underlying: Common Shares, No Par Value · 136,116 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase Common Shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:56 UTC |
Eldessouky SamChief Financial Officer
|
GrantCommon Shares, No Par Value | 42,517 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008774 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,517 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 21:06 UTC |
Bernier Nathalie D.Director
|
GrantCommon Shares, No Par Value | 1,625 | $15.51 | $25,203.75 |
DisclosureSEC source: 0001127602-23-000121 · form4.xml · nonDerivative · entry 1 Bernier Nathalie D. · CIK 0001903043 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,380 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:04 UTC |
Bernier Nathalie D.Director
|
GrantCommon Shares, No Par Value | 1,507 | $15.34 | $23,117.38 |
DisclosureSEC source: 0001127602-22-023432 · form4.xml · nonDerivative · entry 1 Bernier Nathalie D. · CIK 0001903043 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,755 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| July 27, 2022 Filed Jul 27, 2022 23:46 UTC |
Munsch FrederickSVP, Controller and CAO
|
GrantCommon Shares, No Par Value | 11,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019828 · form4.xml · nonDerivative · entry 1 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,722 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following July 25, 2022, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 23:43 UTC |
Hashad YehiaEVP, R&D and CMO
|
GrantCommon Shares, No Par Value | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019827 · form4.xml · nonDerivative · entry 1 Hashad Yehia · CIK 0001877701 · EVP, R&D and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,722 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 23:40 UTC |
Eldessouky SamChief Financial Officer
|
GrantCommon Shares, No Par Value | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019825 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 23:41 UTC |
Gordon Joseph FPlease see remarks
|
GrantCommon Shares, No Par Value | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019826 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Please see remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,444 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 23:38 UTC |
ACKERMANN CHRISTINAPlease see remarks
|
GrantCommon Shares, No Par Value | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019824 · form4.xml · nonDerivative · entry 1 ACKERMANN CHRISTINA · CIK 0001681871 · Please see remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,333 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:12 UTC |
Bernier Nathalie D.Director
|
GrantCommon Shares, No Par Value | 748 | $15.24 | $11,399.52 |
DisclosureSEC source: 0001127602-22-018761 · form4.xml · nonDerivative · entry 1 Bernier Nathalie D. · CIK 0001903043 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,248 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:31 UTC |
Hu GaoxiangDirector
|
GrantCommon Shares, No Par Value | 13,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018300 · form4.xml · nonDerivative · entry 1 Hu Gaoxiang · CIK 0001839091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,256 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the "Company"). The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:23 UTC |
ICAHN BRETTDirector
|
GrantCommon Shares, No Par Value | 13,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018298 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,256 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the "Company"). The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 20:05 UTC |
Bausch Health Companies Inc.10% owner
|
SaleCommon Shares, No Par Value | 4,550,357 | $17.06 | $77,606,338.64 |
DisclosureSEC source: 0000899243-22-020663 · doc4.xml · nonDerivative · entry 1 Bausch Health Companies Inc. · CIK 0000885590 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 310,449,643 F1 · shares: Reflects common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation (the "Issuer") sold to the underwriters in connection with the underwriters' partial exercise of the overallotment option in connection with the initial public offering of the Issuer that closed on May 10, 2022 (the "Offering"). The material terms of the Offering are described in the prospectus dated May 5, 2022, filed by the Issuer with the Securities and Exchange Commission on May 6, 2022. F2 · ownership.nature: Reflects Common Shares owned directly and indirectly by the reporting person through a wholly-owned subsidiary of the reporting person. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:18 UTC |
Bausch Health Companies Inc.10% owner
|
SaleCommon Shares, No Par Value | 35,000,000 | $17.06 | $596,925,000.00 |
DisclosureSEC source: 0000899243-22-017761 · doc4.xml · nonDerivative · entry 1 Bausch Health Companies Inc. · CIK 0000885590 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 315,000,000 F1 · shares: Reflects common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation (the "Issuer") sold to the underwriters pursuant to an Underwriting Agreement, dated May 5, 2020, in connection with the initial public offering of the Issuer, which closed on May 10, 2022 (the "Offering"). The material terms of the Offering are described in the prospectus dated May 5, 2022, filed by the Issuer with the Securities and Exchange Commission on May 6, 2022. F2 · ownership.nature: Reflects Common Shares owned directly and indirectly by the reporting person through a wholly-owned subsidiary of the reporting person. Read SEC document |
| May 10, 2022 Filed May 12, 2022 19:37 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017852 · doc4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the "Company"). F2 · shares: The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date. Read SEC document |
| May 10, 2022 Filed May 12, 2022 23:37 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017854 · doc4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the "Company"). F2 · shares: The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date. Read SEC document |
| May 10, 2022 Filed May 12, 2022 23:40 UTC |
Bernier Nathalie D.Director
|
GrantCommon Shares, No Par Value | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017859 · doc4.xml · nonDerivative · entry 1 Bernier Nathalie D. · CIK 0001903043 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the "Company"). F2 · shares: The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date. Read SEC document |
| May 10, 2022 Filed May 12, 2022 23:38 UTC |
KAVANAGH SARAH BDirector
|
GrantCommon Shares, No Par Value | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017858 · doc4.xml · nonDerivative · entry 1 KAVANAGH SARAH B · CIK 0001681171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the "Company"). F2 · shares: The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date. Read SEC document |
| May 10, 2022 Filed May 12, 2022 23:37 UTC |
Ross Thomas W. Sr.Director
|
GrantCommon Shares, No Par Value | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017855 · doc4.xml · nonDerivative · entry 1 Ross Thomas W. Sr. · CIK 0001669396 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the "Company"). F2 · shares: The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date. Read SEC document |
| May 10, 2022 Filed May 12, 2022 23:37 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017853 · doc4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the "Company"). F2 · shares: The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date. Read SEC document |
| May 10, 2022 Filed May 12, 2022 23:33 UTC |
VON ESCHENBACH ANDREW C.Director
|
GrantCommon Shares, No Par Value | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017847 · doc4.xml · nonDerivative · entry 1 VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the "Company"). F2 · shares: The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date. Read SEC document |
| May 05, 2022 Filed May 9, 2022 22:44 UTC |
Hashad YehiaEVP, R&D and CMO
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 137,362 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017317 · doc4.xml · derivative · entry 2 Hashad Yehia · CIK 0001877701 · EVP, R&D and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,362 Underlying: Common Shares, No Par Value · 137,362 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase Common Shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.